1. The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer
- Author
-
Junyi Hou, Zhenjia Yu, Yifan Lu, Zhongyin Yang, Bingya Liu, Tao Pan, Airong Wu, Liping Su, Zhijian Jin, Xiongyan Wu, Chao Yan, Chen Li, Jianfang Li, Weihua Qiu, Zhenggang Zhu, and Min Yan
- Subjects
Medicine (General) ,Indoles ,QH301-705.5 ,Clinical Biochemistry ,Anlotinib ,Tropomyosin receptor kinase B ,Biochemistry ,Nrf2 ,R5-920 ,Stomach Neoplasms ,Tumor Microenvironment ,medicine ,Humans ,Lactic Acid ,Biology (General) ,Fibroblast ,chemistry.chemical_classification ,Tumor microenvironment ,Reactive oxygen species ,biology ,Brain-Derived Neurotrophic Factor ,Organic Chemistry ,TrkB ,Cancer ,ROS ,Fibroblasts ,medicine.disease ,BDNF ,medicine.anatomical_structure ,nervous system ,chemistry ,Apoptosis ,Quinolines ,Cancer research ,biology.protein ,Antibody ,Tyrosine kinase ,Research Paper - Abstract
Acquired resistance to tyrosine kinase inhibitors (TKIs) is the major obstacle to improve clinical efficacy in cancer patients. The epithelial-stromal interaction in tumor microenvironment influences cancer drug response to TKIs. Anlotinib is a novel oral multi-targeted TKI, and has recently been proven to be effective and safe for several tumors. However, if and how the epithelial-stromal interaction in tumor microenvironment affects anlotinib response in gastric cancer (GC) is not known. In this study, we found that anlotinib inhibited GC cells growth by inducing GC cells apoptosis and G2/M phase arrest in a dose- and time-dependent manner. Reactive oxygen species (ROS) mediated anlotinib-induced apoptosis in GC cells, while cancer-associated fibroblasts (CAFs) significantly suppressed anlotinib-induced apoptosis and ROS in GC cells. Increased BDNF that was derived from CAFs activated TrkB-Nrf2 signaling in GC cells, and reduced GC cells response to anlotinib. We identified secreted lactate from GC cells as the key molecule instructing CAFs to produce BDNF in a NF-κB-dependent manner. Additionally, functional targeting BDNF-TrkB pathway with neutralizing antibodies against BDNF and TrkB increased the sensitivity of GC cells towards anlotinib in human patient-derived organoid (PDO) model. Taken together, these results characterize a critical role of the epithelial-stroma interaction mediated by the lactate/BDNF/TrkB signaling in GC anlotinib resistance, and provide a novel option to overcome drug resistance., Graphical abstract Image 1, Highlights • Anlotinib induced apoptosis through ROS accumulation. • CAFs drive acquired resistance of GC to anlotinib. • TrkB activation by CAFs-derived BDNF confer resistance to anlotinib-induced ROS. • GC cells-secreted lactate induced BDNF expression of CAFs through activating NF-κB. • Blocking BDNF and TrkB reversed CAFs-induced acquired resistance to anlotinib.
- Published
- 2021